Home › Core › ISCC-IDs › 28C4bRwD7u2uA

View ISCC-ID

Core Data

28C4bRwD7u2uA
ISCC-ID - digital asset identifier
CCFhnPzrQh7Qh-CT5BDvwuatz1Z-CDbeENxvV635a-CRKcZwKtM2Nta
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

effects of aluminiumcontaining antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester

Ledger Reference

coblo
Source Ledger/Blockchain
12406841
N-th ISCC Decleration on source ledger
4f962dc2dc4934a891d781e380e8d4727b61e5c1ce5f13924526b42c6b1acb28
Hash of block that includes the ISCC-DECLARATION
54f4595cb2da502af15e1960cbcbcaabcc29dc51dde7b57dfe71c757f3a28ba5
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Effects of Aluminium-Containing Antacid on Bioavailability of Ofloxacin Following Oral Administration of Pivaloyloxymethyl Ester of Ofloxacin as Prodrug.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Yorinobu MAEDA", "@type": "Person"}, {"name": "Kei OMODA", "@type": "Person"}, {"name": "Toshio KONISHI", "@type": "Person"}, {"name": "Makoto TAKAHASHI", "@type": "Person"}, {"name": "Kenji KIHIRA", "@type": "Person"}, {"name": "Satoshi HIBINO", "@type": "Person"}, {"name": "Satsuki TSUKIAI", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.jstage.jst.go.jp/article/bpb1993/16/6/16_6_594/_pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Pharmaceutical Society of Japan", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1248/bpb.16.594", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCFhnPzrQh7Qh-CT5BDvwuatz1Z-CDbeENxvV635a-CRKcZwKtM2Nta", "propertyID": "ISCC"}], "datePublished": "1993-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close